Unraveling the roles of miRNAs in regulating epithelial-to-mesenchymal transition (EMT) in osteosarcoma

Pharmacol Res. 2021 Oct:172:105818. doi: 10.1016/j.phrs.2021.105818. Epub 2021 Aug 13.

Abstract

Osteosarcoma is one of the most prevalent primary bone tumors with a high metastatic and recurrence rate with poor prognosis. MiRNAs are short and non-coding RNAs that could regulate various cellular activities and one of them is the epithelial-to-mesenchymal transition (EMT). Osteosarcoma cells that have undergone EMT would lose their cellular polarity and acquire invasive and metastatic characteristics. Our literature search showed that many pre-clinical and clinical studies have reported the roles of miRNAs in modulating the EMT process in osteosarcoma and compared to other cancers like breast cancer, there is a lack of review article which effectively summarizes the various roles of EMT-regulating miRNAs in osteosarcoma. This review, therefore, was aimed to discuss and summarize the EMT-promoting and EMT-suppressing roles of different miRNAs in osteosarcoma. The review would begin with the discussion on the concepts and principles of EMT, followed by the exploration of the diverse roles of EMT-regulating miRNAs in osteosarcoma. Subsequently, the potential use of miRNAs as prognostic biomarkers in osteosarcoma to predict the likelihood of metastases and as therapeutic agents would be discussed.

Keywords: Biomarker; EMT-regulating miRNAs; Epithelial-to-mesenchymal transition (EMT); MiRNAs; Osteosarcoma; Therapeutic agent.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bone Neoplasms / genetics*
  • Bone Neoplasms / therapy
  • Epithelial-Mesenchymal Transition*
  • Humans
  • MicroRNAs*
  • Osteosarcoma / genetics*
  • Osteosarcoma / therapy

Substances

  • MicroRNAs